top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Emerging Paradigms in Insulin Resistance
Emerging Paradigms in Insulin Resistance
Autore Burke Susan J
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (190 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato acute intermittent porphyria
adipokines
apoptosis
beta hydroxybutyrate
beta-hydroxybutyrate
bone mineral density
CAD severity
carbohydrate loading therapy
collagen
diabetes
endoplasmic reticulum stress
epicardial adipose tissue
experimental liver-targeted insulin
fast-acting insulin
fragility fractures
genetic models
glucagon
glucagon-like peptide-1
glucosamine
glucose intolerance
glucose transporters
hydroxyapatite
hyperglycaemia
hyperinsulinaemia
hyperinsulinemia
hypertrophy of adipocytes
inflammation
insulin receptor
insulin resistance
insulin-degrading enzyme
liver
metabolic disease
metabolomics
n/a
Negr1
obesity
osteocalcin
osteocalin
osteoporosis
ovariectomy
pancreas
pancreatic β-cell dysfunction
phenotype
raloxifene
serotonin
stages
thiazolidinedione
type 2 diabetes
vitamin D
ISBN 3-0365-5366-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910619471703321
Burke Susan J  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
Autore Mager Hans-Jurgen
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (228 p.)
Soggetto topico Research and information: general
Soggetto non controllato activin receptor-like kinase 1 (ALK1)
activin-receptor-like kinase 1
ACVRL1
ALK1
angiogenesis
antiangiogenic properties
anticoagulants
antiplatelets
antithrombotic therapy
arteriovenous malformation
arteriovenous malformation (AVM)
arteriovenous malformations (AVMs)
AVM
bazedoxifene
bevacizumab
biomarker
biomarkers
bleeding
bone morphogenetic protein (BMP)
catheter based embolization therapy
cell adhesion
cerebral ischemic lesions
contrast enhanced magnetic resonance angiography
endoglin
Endoglin
endothelial cells
ENG
epistaxis
epistaxis severity score
etamsylate
FK506
gastrointestinal bleeding
genetic disease
genotype-phenotype correlation
guidelines
hereditary hemorrhagic
hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia
Hereditary Hemorrhagic Telangiectasia
hereditary hemorrhagic telangiectasia (HHT)
hereditary hemorrhagic telangiectasia (HHT), second-hit
hereditary hemorrhagic telangiectasia/HHT/osler's disease
HHT
inflammation
life expectancy
liver
long non-coding RNAs
mechanical damage
microRNA
microRNAs
MRI
N-acetylcysteine
nasal endoscopy
nasal ointment
non-coding RNAs
nosebleeds
Osler-Weber-Rendu
pediatrics
plasma
propranolol
propranolol gel
pulmonary arteriovenous malformation
pulmonary arteriovenous malformations
raloxifene
rare disease
rare diseases
safety
screening
shear stress
Smad pathway
Smad4
SMAD4
somatic mutation
sun-induced trauma
survival
tacrolimus
telangiectases
telangiectasia
telangiectasis
tranexamic acid
transcatheter embolotherapy
transforming growth factor beta (TGF-β)
transforming growth factor-beta (TGF-β)
ultrasound
vascular endothelial growth factor (VEGF)
vascular injury
vascular malformations
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Hereditary Hemorrhagic Telangiectasia
Record Nr. UNINA-9910557578003321
Mager Hans-Jurgen  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui